MicroRNA signatures characterize diffuse large B‐cell lymphomas and follicular lymphomas

No abstract is available for this paper.

• Publication year

  2008

• Venue

  British Journal of Haematology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2008.07237.xPMID 18537969
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells*

  2008cited by this paper
• MicroRNA expression profiles of esophageal cancer.

  2008cited by this paper
• MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

  2008cited by this paper
• Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma.

  2008cited by this paper
• MicroRNAs modulate the chemosensitivity of tumor cells

  2008cited by this paper
• Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer

  2008cited by this paper
• miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

  2008cited by this paper
• How do microRNAs regulate gene expression?

  2008cited by this paper
• Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

  2007cited by this paper
• miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely

  2007cited by this paper
• Differential Regulation of microRNAs by p53 Revealed by Massively Parallel Sequencing: miR-34a is a p53 Target That Induces Apoptosis and G1-arrest

  2007cited by this paper
• Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.

  2007cited by this paper
• Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

  2007cited by this paper
• MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

  2007cited by this paper
• miR-21-mediated tumor growth

  2007cited by this paper
• How Do MicroRNAs Regulate Gene Expression?

  2007cited by this paper
• MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

  2007cited by this paper
• MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis

  2007cited by this paper
• Regulation of the Germinal Center Response by MicroRNA-155

  2007cited by this paper
• Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

  2007cited by this paper
• Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

  2007cited by this paper
• MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.

  2007cited by this paper
• Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma

  2007influential reference
• Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.

  2007cited by this paper
• miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia.

  2007cited by this paper
• A microRNA component of the p53 tumour suppressor network

  2007cited by this paper
• MicroRNA expression profiles in head and neck cancer cell lines.

  2007cited by this paper
• MicroRNA signatures in human ovarian cancer.

  2007cited by this paper
• Requirement of bic/microRNA-155 for Normal Immune Function

  2007cited by this paper
• MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)*

  2007cited by this paper
• Patterns of known and novel small RNAs in human cervical cancer.

  2007cited by this paper
• Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• microRNA target predictions in animals

  2006cited by this paper
• Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

  2006cited by this paper
• Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

  2006cited by this paper
• Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

  2006cited by this paper
• Expression profiling identifies microRNA signature in pancreatic cancer

  2006cited by this paper
• MicroRNA deregulation in human thyroid papillary carcinomas.

  2006cited by this paper
• MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.

  2006cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• Genomics of microRNA.

  2006cited by this paper
• A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

  2006cited by this paper
• Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer.

  2006cited by this paper
• Control of translation and mRNA degradation by miRNAs and siRNAs.

  2006cited by this paper
• Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.

  2006cited by this paper
• A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.

  2005cited by this paper
• Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

  2005cited by this paper
• Prostate Stem Cell Antigen Is Overexpressed in Prostate Cancer Metastases

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• c-Myc-regulated microRNAs modulate E2F1 expression

  2005cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling.

  2005cited by this paper
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

  2005influential reference
• BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas

  2005cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Performance of some variable selection methods when multicollinearity is present

  2005cited by this paper
• Small molecule inhibitors of IκB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling

  2005cited by this paper
• Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

  2004cited by this paper
• A global test for groups of genes: testing association with a clinical outcome

  2004cited by this paper
• High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma

  2004cited by this paper
• Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs.

  2004cited by this paper
• MicroRNAs Modulate Hematopoietic Lineage Differentiation

  2004cited by this paper
• Nuclear Export of MicroRNA Precursors

  2004cited by this paper
• Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

  2004cited by this paper
• Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

  2004cited by this paper
• Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• MicroRNA genes are transcribed by RNA polymerase II

  2004cited by this paper
• The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism.

  2003cited by this paper
• bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila.

  2003cited by this paper
• The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

  2003cited by this paper
• Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs.

  2003cited by this paper
• Statistical methods for identifying differentially expressed genes in DNA microarrays.

  2003cited by this paper
• The nuclear RNase III Drosha initiates microRNA processing

  2003cited by this paper
• Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• High expression of B‐cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma

  2002cited by this paper
• Reviving China's ruined rivers.

  2002cited by this paper
• The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

  2002influential reference
• The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.

  2002cited by this paper
• MicroRNA maturation: stepwise processing and subcellular localization

  2002cited by this paper
• A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA

  2001cited by this paper
• Controlling the false discovery rate in behavior genetics research.

  2001cited by this paper
• Design of Experiments, Principles and Applications, L. Eriksson, E. Johansson, N. Kettaneh‐ Wold, C. Wikström and S. Wold, Umetrics AB, Umeå Learnways AB, Stockholm, 2000, ISBN 91‐973730‐0‐1, xii + 329 pp.

  2001cited by this paper
• Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

  2001cited by this paper
• Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

  1997cited by this paper
• A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project

  1997cited by this paper
• The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

  1993cited by this paper
• Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans.

  1993cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Epigenetic dysregulation of B-cells in autoimmune diseases and lymphomas (Review)

  2026cites this paper
• The Epigenetic Angle in the Precision Medicine Era for Blood Disorder Advancements.

  2026cites this paper
• MicroRNA as a Potential Diagnostic and Prognostic Biomarker in Diffuse Large B‐Cell Lymphoma: A Systematic Review and Meta‐Analysis

  2025cites this paper
• A Preliminary Association Study of H19 Non‐Coding Gene Variants With Risk of Non‐Hodgkin Lymphoma: A Case–Control Study and Computational Analysis

  2025cites this paper
• Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma

  2025cites this paper
• CXCR 4, PAX5, and OCT2 Immunohistochemical Expressions in Diffuse Large B-Cell Lymphoma and Their Relationship with XIST/miR-34/PAX5 Axis

  2025cites this paper
• MicroRNA Expression in High‐Grade B‐Cell Lymphoma With 11q Aberration

  2025cites this paper
• Identification of human microRNA-disease association via low-rank approximation-based link propagation and multiple kernel learning

  2024cites this paper
• MicroRNA Expression in Exosome Extracellular Vesicles as Targets for Personalized Medicine in Diffuse Large B Cell Lymphoma Patients with HIV Infection.

  2024cites this paper
• The Role of microRNA-155 as a Biomarker in Diffuse Large B-Cell Lymphoma

  2024cites this paper
• Profiles of differential expression of miRNAs in the late stage of red blood cell preservation and their potential roles.

  2024cites this paper
• Helicobacter pylori and its role in the pathogenesis of follicular gastritis: an overview.

  2024cites this paper
• microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

  2023cites this paper
• Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas

  2023cites this paper
• Relationship between cluster miR-143/145 micro-RNAs with oncogenesis: tissue and cellular context

  2023cites this paper
• Changes in the <i>MIR-143</i. gene methylation pattern in the tumor tissue of the diffuse large B-cell lymphoma

  2023cites this paper
• Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma

  2023cites this paper
• Using the Precision Lasso for gene selection in diffuse large B cell lymphoma cancer

  2023cites this paper
• MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas

  2023cites this paper
• Host microRNAs are differentially expressed in EBV+ Post-transplant Lymphoproliferative Disorder solid-organ transplant recipients

  2022cites this paper
• Methylation of p53-responsive oncosuppressive microRNA genes in hemoblastosis

  2022cites this paper
• Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder

  2022cites this paper
• Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas

  2022cites this paper
• Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics

  2022cites this paper
• MicroRNA and Other Non-Coding RNAs in Epstein–Barr Virus-Associated Cancers

  2021cites this paper
• A B-cell developmental gene regulatory network is activated in infant AML

  2021cites this paper
• The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas

  2021cites this paper
• Non-coding RNAs (miRNAs and lncRNAs) and their roles in lymphogenesis in all types of lymphomas and lymphoid malignancies

  2021cites this paper
• Systematic Review of the Potential of MicroRNAs in the Management of Patients with Follicular Lymphoma.

  2021cites this paper
• Distinct microRNA expression signatures of primary and secondary central nervous system lymphomas.

  2021cites this paper
• New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas

  2021cites this paper
• Biology of splenic and nodal marginal zone lymphomas

  2021cites this paper
• Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p

  2020cites this paper
• Diagnosis and treatment of lymphomas in the era of epigenetics.

  2020cites this paper
• The Role of Noncoding RNAs in B-Cell Lymphoma

  2020cites this paper
• MicroRNA-7 Regulates Migration and Chemoresistance in Non-Hodgkin Lymphoma Cells Through Regulation of KLF4 and YY1

  2020cites this paper
• Non-Coding RNAs in Diffuse Large B-Cell Lymphoma

  2020cites this paper
• miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma

  2020cites this paper
• Inhibition of YBX1 by miR-216a Suppresses Proliferation and Invasion of Diffuse Large B-Cell Lymphoma

  2020cites this paper
• Systematic Review of the Potential of MicroRNAs in Diffuse Large B Cell Lymphoma

  2019influential citation
• MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma

  2019cites this paper
• Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations

  2019cites this paper
• MALT Lymphoma as a Model of Chronic Inflammation-Induced Gastric Tumor Development.

  2019cites this paper
• Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP

  2019cites this paper
• Aberrant ERG expression associates with downregulation of miR‐4638‐5p and selected genomic alterations in a subset of diffuse large B‐cell lymphoma

  2019cites this paper
• MicroRNA profiles in B-cell non-Hodgkin lymphoma

  2019influential citation
• Effect of rituximab combined with chemotherapy on the expression of serum exosome miR-451a in patients with diffuse large b-cell lymphoma.

  2019cites this paper
• Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma

  2019cites this paper
• Cross-talk between Myc and p53 in B-cell lymphomas

  2019cites this paper
• Dysregulated expressions of PTEN, NF-κB, WWP2, p53 and c-Myc in different subtypes of B cell lymphoma and reactive follicular hyperplasia.

  2019cites this paper
• Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance.

  2019cites this paper
• MicroRNA profiling in canine multicentric lymphoma

  2019cites this paper
• Clinical significance of aberrant microRNAs expression in predicting disease relapse/refractoriness to treatment in diffuse large B-cell lymphoma: A meta-analysis.

  2019cites this paper
• MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma

  2018influential citation
• Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma

  2018cites this paper
• Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study

  2018cites this paper
• MDA-SKF: Similarity Kernel Fusion for Accurately Discovering miRNA-Disease Association

  2018cites this paper
• Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study

  2018cites this paper
• MicroRNAs as Biomarkers of B-cell Lymphoma

  2018cites this paper
• MiRNA Dysregulation in Childhood Hematological Cancer

  2018cites this paper
• Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA

  2018cites this paper
• MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways

  2018cites this paper
• Over expression of circulating miR-155 predicts prognosis in diffuse large B-cell lymphoma.

  2018cites this paper
• Expression Signature of MicroRNA-155 and its Association with Response to Treatment within Different Subtypes of B-Cell Malignancies

  2017cites this paper
• NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

  2017cites this paper
• Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53

  2017cites this paper
• miRNAs in B-cell lymphoma: Molecular mechanisms and biomarker potential.

  2017cites this paper
• MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis.

  2017cites this paper
• The Diagnostic and Prognostic Impact of Serum miRNA-21 in a Sample of Hepatitis C/None Hepatitis Diffuse Large B Cell Lymphoma Egyptian Patients

  2017cites this paper
• MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma

  2017cites this paper
• Identification and characterisation of micrornas involved in the pathogenesis of HIV–associated non-Hodgkin's lymphoma

  2017cites this paper
• Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations

  2017cites this paper
• Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma

  2017cites this paper
• Testing for association between RNA-Seq and high-dimensional data

  2016cites this paper
• miR-4284 and miR-4484 as Putative Biomarkers for Diffuse Large B-Cell Lymphoma

  2016cites this paper
• Diffuse Large B-cell lymphoma: Prognostic markers and their impact on therapy

  2016cites this paper
• High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.

  2016cites this paper
• Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma

  2016influential citation
• Effect of Environmental Chemical Exposures on Epigenetics of Diseases: A Systematic Review

  2016cites this paper
• miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma

  2016cites this paper
• Aberrant expression of MicroRNAs in B-cell lymphomas.

  2016cites this paper
• MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma.

  2016cites this paper
• miR-155 as a Biomarker in B-Cell Malignancies

  2016cites this paper
• MicroRNAs in diffuse large B-cell lymphoma.

  2016influential citation
• miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.

  2016cites this paper
• Molecular genetics related to non-Hodgkin lymphoma

  2016cites this paper
• BRIEF REPORT: MIR-4284 AND MIR-4484 AS PUTATIVE BIOMARKERS FOR DIFFUSE LARGE B-CELL LYMPHOMA

  2016cites this paper
• Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis

  2016cites this paper
• The expression and clinical significance of microRNA-34 a in diffuse lager B-cell lymphoma

  2016cites this paper
• МикроРНК: малые молекулы с большим значением

  2015cites this paper
• Molecular analysis of aggressive B-cell lymphomas

  2015cites this paper
• Short-Circuiting Gene Regulatory Networks: Origins of B Cell Lymphoma.

  2015cites this paper
• MicroRNA 21 Expression Levels in HIV Negative and HIV Positive Diffuse Large B Cell Lymphoma

  2015cites this paper
• MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma.

  2015cites this paper
• MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential

  2015cites this paper
• Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

  2015cites this paper
• Identificación de marcadores de utilidad diagnóstica y pronóstica en linfoma B de célula grande agresivo: = Identification of diagnostic and prognostic markers in aggressive large B cell lymphoma

  2015cites this paper
• A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia

  2015cites this paper
• miR-21 expression predicts prognosis in diffuse large B-cell lymphoma.

  2015cites this paper
• MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.

  2015influential citation